Skip to content
★ Sign in to follow
GB

G B Phillips

Board Director
Tissue Regenix Group plc
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€108k
▼ Sales (0 ops.)
—

Latest filing published 24 Sept 2021 for Tissue Regenix Group plc, €64k.

Filing timeline

BuySale
G B Phillips

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

G B Phillips: trading record in brief

G B Phillips appears in our data through filings on Tissue Regenix Group plc shares, published by RNS (LSE). We count 3 filings; the first trade dates from 18 June 2021 and the latest from 23 September 2021.

Every open-market trade on record is a purchase: 3 purchases worth €108k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Half of the purchases are above €24k and half below. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 24 September 2021: an open-market purchase of €64k, in Tissue Regenix Group plc. Filings reach the RNS (LSE) feed a median of 4 days after the trade. For comparison, UK MAR gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.

Companies and markets linked to G B Phillips

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    Non-executive directorExecutivesTissue Regenix Group plc
    54,729 GBP25FCA-NSM
    9,000,000 shares@ £0.006159.1% of flowLondon Stock Exchange, AIM MarketISIN GB00B5SGVL29FCA-NSM:4121658
    Canonical exit: 22 Dec 2021 (T+90)
  • ▲
    Non-Executive DirectorExecutivesTissue Regenix Group plc
    17,320 GBP9FCA-NSM
    2,886,671 shares@ £0.00618.7% of flowLondon Stock Exchange, AIM MarketISIN GB00B5SGVL29FCA-NSM:4025461
    Canonical exit: 23 Sept 2021 (T+90)
  • ▲
    Non-Executive DirectorExecutivesTissue Regenix Group plc
    20,617 GBP9FCA-NSM
    3,436,085 shares@ £0.00622.3% of flowLondon Stock Exchange, AIM MarketISIN GB00B5SGVL29FCA-NSM:4019450
    Canonical exit: 16 Sept 2021 (T+90)

3 of 3 declarations